Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Peptic Ulcer

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    November 2021
  1. ABY ES, Tappata M, Rodin H, Debes JD, et al
    Assessment of proton-pump inhibitor use, race, socioeconomic status, and mortality in individuals with COVID-19.
    Eur J Gastroenterol Hepatol. 2021 Nov 23. pii: 00042737-900000000-97121.
    PubMed    


    September 2021
  2. SONCINI M, Occhipinti V, Zullo A, Marmo R, et al
    No evidence of "weekend effect" in upper gastrointestinal bleeding in Italy: data from a nationwide prospective registry.
    Eur J Gastroenterol Hepatol. 2021 Sep 21. pii: 00042737-900000000-97144.
    PubMed     Abstract available


  3. SARBINOWSKA J, Wiatrak B, Wasko-Czopnik D
    Association between Schatzki ring and eosinophilic esophagitis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2021;33:1167-1173.
    PubMed     Abstract available


    March 2021
  4. DE FRANCESCO V, Zullo A, Manta R, Gatta L, et al
    Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review.
    Eur J Gastroenterol Hepatol. 2021 Mar 19. pii: 00042737-900000000-97264.
    PubMed     Abstract available


  5. MOHAPATRA S, Charilaou P, Korman A
    Not all upper gastrointestinal bleeds in cirrhotics are variceal!
    Eur J Gastroenterol Hepatol. 2021;33:448-450.
    PubMed    


    February 2021
  6. SIRIN G, Sezikli M, Eruyar AT, Dindar G, et al
    Duodenal bulb infection may be a risk factor for Helicobacter pylori eradication insuccess.
    Eur J Gastroenterol Hepatol. 2021;32:303-304.
    PubMed    


    December 2020
  7. STURM L, Muller L, Schultheiss M, Binder B, et al
    Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002018.
    PubMed     Abstract available


    November 2020
  8. RAMACHANDRAN P, Perisetti A, Gajendran M, Jean-Louis F, et al
    Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.
    Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002013.
    PubMed     Abstract available


  9. HIRAI R, Shimodate Y, Minami M, Ishikawa S, et al
    AIMS65 predicts prognosis of patients with duodenal ulcer bleeding; a comparison with other risk-scoring systems.
    Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002010.
    PubMed     Abstract available


  10. AZIZ M, Dasari CS, Zafar Y, Fatima R, et al
    Does timing of endoscopy affect outcomes in patients with upper gastrointestinal bleeding: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Nov 10. doi: 10.1097/MEG.0000000000001975.
    PubMed     Abstract available


    October 2020
  11. ZHAO S, Ding L, Xie Q, Zhang J, et al
    Is there an association between peptic ulcer disease and osteoporosis: a systematic review and cumulative analysis.
    Eur J Gastroenterol Hepatol. 2020 Oct 29. doi: 10.1097/MEG.0000000000001981.
    PubMed     Abstract available


    September 2020
  12. BALLA A, Leone G, Ribichini E, Sacchi MC, et al
    Gastroesophageal Reflux Disease - Health-Related Quality of Life Questionnaire: prospective development and validation in Italian.
    Eur J Gastroenterol Hepatol. 2020 Sep 9. doi: 10.1097/MEG.0000000000001914.
    PubMed     Abstract available


    August 2020
  13. GHOZ H, Patel P, Stancampiano F, Patel S, et al
    Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort study.
    Eur J Gastroenterol Hepatol. 2020 Aug 28. doi: 10.1097/MEG.0000000000001905.
    PubMed     Abstract available


  14. LI H, Xia XJ, Zhang LF, Chi JS, et al
    Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study.
    Eur J Gastroenterol Hepatol. 2020 Aug 14. doi: 10.1097/MEG.0000000000001896.
    PubMed     Abstract available


  15. DIRWEESH A, Anugwom CM, Li Y, Vaughn BP, et al
    Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Aug 4. doi: 10.1097/MEG.0000000000001857.
    PubMed     Abstract available


    July 2020
  16. XU H, Wang W, Ma X, Feng R, et al
    Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 Jul 3. doi: 10.1097/MEG.0000000000001835.
    PubMed     Abstract available


    June 2020
  17. KALKANLI TAS S, Kirkik D, Tanoglu A, Kahraman R, et al
    Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2020 Jun 11. doi: 10.1097/MEG.0000000000001797.
    PubMed     Abstract available


  18. KHAN MY, Aslam A, Mihali AB, Shabbir Rawala M, et al
    Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020;32:686-694.
    PubMed     Abstract available


    May 2020
  19. IKEDA R, Hirasawa K, Sato C, Sawada A, et al
    Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.
    Eur J Gastroenterol Hepatol. 2020 May 29. doi: 10.1097/MEG.0000000000001788.
    PubMed     Abstract available


  20. KHAN MY, Aslam A, Mihali AB, Shabbir Rawala M, et al
    Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2020 May 2. doi: 10.1097/MEG.0000000000001740.
    PubMed     Abstract available


    April 2020
  21. KAMAL F, Khan MA, Tariq R, Ismail MK, et al
    Systematic review and meta-analysis: monopolar hemostatic forceps with soft coagulation in the treatment of peptic ulcer bleeding.
    Eur J Gastroenterol Hepatol. 2020 Apr 20. doi: 10.1097/MEG.0000000000001738.
    PubMed     Abstract available


    January 2020
  22. ZULLO A
    The current role of dual therapy for treatment of Helicobacter pylori: back to the future?
    Eur J Gastroenterol Hepatol. 2020 Jan 8. doi: 10.1097/MEG.0000000000001654.
    PubMed    


    December 2019
  23. ZHANG Y, Zhu YJ, Zhao Z, Zhao JT, et al
    Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.
    Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001646.
    PubMed     Abstract available


    November 2019
  24. CHEN C, Zhang C, Wang X, Zhang F, et al
    Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.
    Eur J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1097/MEG.0000000000001601.
    PubMed     Abstract available


    October 2019
  25. DURICEK M, Banovcin P Jr, Halickova T, Hyrdel R, et al
    Comprehensive analysis of acidic pharyngeal reflux before and after proton pump inhibitor treatment in patients with suspected laryngopharyngeal reflux.
    Eur J Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1097/MEG.0000000000001584.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: